Health care startups that raised Series A in the United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| OSSTEC | London | Series A | $8.0M | 2026-11-03 |
| Bioliberty | Edinburgh | Series A | $3.3M | 2026-11-02 |
| Adsilico | Leeds | Series A | $13.3M | 2026-10-26 |
| Dyad | London | Series A | $10.0M | 2026-09-29 |
| Living Optics | Milton Keynes | Series A | $20.0M | 2026-09-24 |
| Alchemab Therapeutics | London | Series A | $33.6M | 2026-07-09 |
| Apoha | London | Series A | $36.0M | 2026-06-03 |
| Lucida Medical | Cambridge | Series A | $11.5M | 2026-03-30 |
8 rows of the CSV in 5 of its 18 columns.
- The 214 health care startups in the United Kingdom whose last round is Series A have raised $3.4B in total.
- 34 of them closed their most recent round in the last 12 months, $916.9M combined.
- The largest of those rounds is RQ Bio's $112.5M Series A, dated June 2026.
- The most recent is Alethio Therapeutics' $90.0M Series A on 5 November 2026.
- Parkwalk Advisors is an investor in 6 of them, more than any other fund.
- Biotech is the most common other sector, with 91 companies (43%).
- 25% were founded in 2020 or later; the median founding year is 2016.
- The most common team size is 11 to 50 employees (61% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
21 of 214| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
| Bioliberty | Bioliberty develops rehabilitation solutions for degenerative and traumatic conditions as a medtech start-up. | Biotech | Edinburgh | Series A | $3.3M | 2026-11-02 | $17.4M | Innovate UK, Scottish Enterprise, Old College Capital +2 | 11 to 50 | 2020 |
| Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| Dyad | Dyad builds trust in data and develops AI-powered tools for healthcare operations. | Artificial intelligence | London | Series A | $10.0M | 2026-09-29 | $14.0M | Plug and Play, Pantera Capital, Carbide Ventures | 11 to 50 | 2020 |
| Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | London | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| Lucida Medical | Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. | Biotech | Cambridge | Series A | $11.5M | 2026-03-30 | $22.5M | Innovate UK, XTX Ventures, WDH Investments | 11 to 50 | 2019 |
| Eolas Medical | Eolas Medical organizes medical information worldwide to make healthcare simpler, safer, and smarter. | Health care | Belfast | Series A | $12.1M | 2026-01-20 | $12.1M | Ascension, 7percent Ventures | 11 to 50 | 2019 |
| EpilepsyGTx | EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. | Biotech | Canterbury | Series A | $33.0M | 2025-12-10 | $43.0M | UCL Technology Fund, HTH | 1 to 10 | 2021 |
| Mirna | Mirna develops veterinary disease testing technology for animal diagnostics. | Health care | Whitburn | Series A | $3.6M | 2025-12-10 | $8.6M | Scottish Enterprise, Michelson Impact Ventures, Leap Venture Studio +2 | 1 to 10 | 2019 |
| PolyModels Hub | PolyModels Hub provides modeling, simulation, and data services to accelerate drug development. | Health care | London | Series A | $9.2M | 2025-11-20 | $10.6M | Marathon Venture Capital | 11 to 50 | 2023 |
| Insight Surgery | Insight Surgery digitizes surgical planning and supplies patient-specific medical devices to carry out those plans. | Hardware | Liverpool | Series A | $2.5M | 2025-05-14 | $4.8M | Fenwall Investments | 11 to 50 | 2015 |
| Verdiva Bio | Verdiva Bio develops treatments for patients with obesity and cardiometabolic diseases. | Biotech | London | Series A | $411.0M | 2025-01-09 | $411.0M | General Atlantic, RA Capital Management, OrbiMed +1 | 11 to 50 | 2024 |
| OxCan | OxCan develops machine learning and liquid biopsy tools for early lung cancer detection. | Biotech | Oxford | Series A | $11.0M | 2025-01-09 | $16.4M | Civilization Ventures, Eka Ventures, Oxford Technology Management +1 | 11 to 50 | 2020 |
| Oxford Endovascular | Oxford Endovascular develops a novel treatment for brain aneurysms. | Biotech | Oxford | Series A | $10.2M | 2024-05-20 | $28.4M | Innovate UK, MedTech Innovator, Parkwalk Advisors +1 | 1 to 10 | 2015 |
| Mogrify | Mogrify develops in vivo reprogramming therapies for patients with degenerative diseases. | Biotech | Cambridge | Series A | $10.0M | 2023-10-02 | Parkwalk Advisors, 24 Haymarket, Ahren Innovation Capital | 11 to 50 | 2019 | |
| Sitryx Therapeutics | Sitryx Therapeutics develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation. | Biotech | Oxford | Series A | $39.0M | 2023-09-27 | Sofinnova Partners, Oxford Science Enterprises, SV Health Investors +1 | 11 to 50 | 2018 | |
| Optellum | Optellum develops an imaging biomarker for smart lung cancer detection. | Artificial intelligence | Oxford | Series A | $14.0M | 2022-09-27 | IQ Capital, Mercia Fund Managers, Intuitive Ventures +1 | 11 to 50 | 2016 | |
| Opinsta | Opinsta provides a platform for managing quality assurance defect reports, safety checks, inspections, and third-party maintenance. | Fintech | Birmingham | Series A | $1.9M | 2019-10-31 | Ascension, West Hill Capital | 11 to 50 | 2013 | |
| Aston EyeTech Ltd | Aston EyeTech is an Aston University spin-out that develops products for practising optometrists. | Hardware | Birmingham | Series A | $6.6M | 2017-11-17 | Ascension, Mercia Fund Managers, Mercia Asset Management +2 | 1 to 10 | 2013 |
Table 1. Health care startups that raised Series A in the United Kingdom: the 21 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 214.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Apoha | Apoha is a start-up that has not yet publicly launched. | Biotech | London | Series A | $36.0M | 2026-06-03 | $36.0M | Plug and Play, Innovate UK, Intel Ignite +2 | 1 to 10 | 2021 |
| 2 | Alchemab Therapeutics | Alchemab Therapeutics develops protective antibodies to prevent hard-to-treat diseases. | Biotech | London | Series A | $33.6M | 2026-07-09 | $151.1M | DCVC, RA Capital Management, DHVC +2 | 51 to 100 | 2019 |
| 3 | EpilepsyGTx | EpilepsyGTx develops gene therapies to improve management of focal refractory epilepsy in late-stage clinical development. | Biotech | Canterbury | Series A | $33.0M | 2025-12-10 | $43.0M | UCL Technology Fund, HTH | 1 to 10 | 2021 |
| 4 | Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| 5 | Adsilico | Adsilico develops new approaches to medical device innovation. | Health care | Leeds | Series A | $13.3M | 2026-10-26 | $17.8M | Parkwalk Advisors, Northern Gritstone | 1 to 10 | 2022 |
| 6 | Eolas Medical | Eolas Medical organizes medical information worldwide to make healthcare simpler, safer, and smarter. | Health care | Belfast | Series A | $12.1M | 2026-01-20 | $12.1M | Ascension, 7percent Ventures | 11 to 50 | 2019 |
| 7 | Lucida Medical | Lucida Medical develops software for cancer diagnosis using MRI and radiology imaging, particularly for prostate cancer. | Biotech | Cambridge | Series A | $11.5M | 2026-03-30 | $22.5M | Innovate UK, XTX Ventures, WDH Investments | 11 to 50 | 2019 |
| 8 | Dyad | Dyad builds trust in data and develops AI-powered tools for healthcare operations. | Artificial intelligence | London | Series A | $10.0M | 2026-09-29 | $14.0M | Plug and Play, Pantera Capital, Carbide Ventures | 11 to 50 | 2020 |
| 9 | PolyModels Hub | PolyModels Hub provides modeling, simulation, and data services to accelerate drug development. | Health care | London | Series A | $9.2M | 2025-11-20 | $10.6M | Marathon Venture Capital | 11 to 50 | 2023 |
| 10 | OSSTEC | OSSTEC develops products for orthopaedic treatment. | Hardware | London | Series A | $8.0M | 2026-11-03 | $12.7M | SFC Capital, Parkwalk Advisors, Embryo Ventures +1 | 11 to 50 | 2021 |
Table 2. Health care startups that raised Series A in the United Kingdom: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 6 | 3% | 2 | OSSTEC, Adsilico |
| 2 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 6 | 3% | 3 | Bioliberty, Apoha, Lucida Medical |
| 3 | Scottish Enterprise | Government investment office | Glasgow, United Kingdom | 4 | 2% | 2 | Bioliberty, Mirna |
| 4 | Ascension | Micro VC fund | London, United Kingdom | 4 | 2% | 1 | Eolas Medical |
| 5 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | 3 | 1% | 1 | Living Optics |
| 6 | Plug and Play | Startup accelerator | Sunnyvale, United States | 2 | 1% | 2 | Dyad, Apoha |
| 7 | Octopus Ventures | Venture capital firm | London, United Kingdom | 2 | 1% | 1 | Living Optics |
| 8 | SV Health Investors | Private equity firm | Boston, United States | 2 | 1% | 1 | Alchemab Therapeutics |
| 9 | RA Capital Management | Startup incubator | Boston, United States | 2 | 1% | 1 | Alchemab Therapeutics |
| 10 | Equity Gap | Angel group | Edinburgh, United Kingdom | 2 | 1% | 1 | Mirna |
| 11 | Meridian Health Ventures | Private equity firm | London, United Kingdom | 2 | 1% | ||
| 12 | Sofinnova Partners | Venture capital firm | Paris, France | 2 | 1% | ||
| 13 | Index Ventures | Venture capital firm | San Francisco, United States | 2 | 1% | ||
| 14 | JamJar Investments | Venture capital firm | London, United Kingdom | 2 | 1% | ||
| 15 | IQ Capital | Venture capital firm | London, United Kingdom | 2 | 1% |
Table 3. Health care startups that raised Series A in the United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Biotech | 91 | 43% | $2.2B |
| Software | 52 | 24% | $573.1M |
| Artificial intelligence | 22 | 10% | $411.9M |
| Hardware | 18 | 8% | $111.2M |
| Fintech | 9 | 4% | $19.2M |
| Commerce | 9 | 4% | $16.9M |
| Education | 4 | 2% | $18.0M |
| Cybersecurity | 1 | 0% | $49.3M |
| Energy | 1 | 0% |
Table 4. Health care startups that raised Series A in the United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series A | 214 | 100% | $10.0M |
Table 5. Health care startups that raised Series A in the United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| London | 98 | 46% |
| Cambridge | 17 | 8% |
| Oxford | 17 | 8% |
| Edinburgh | 7 | 3% |
| Birmingham | 6 | 3% |
| Manchester | 5 | 2% |
| Milton Keynes | 3 | 1% |
| Altrincham | 3 | 1% |
| Coventry | 3 | 1% |
| Abingdon | 3 | 1% |
| Leeds | 2 | 1% |
| Nottingham | 2 | 1% |
Table 6. Health care startups that raised Series A in the United Kingdom by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 3 | 9% | $101.3M |
| October 2026 | 4 | 12% | $93.3M |
| September 2026 | 5 | 15% | $133.0M |
| July 2026 | 1 | 3% | $33.6M |
| June 2026 | 8 | 24% | $312.6M |
| May 2026 | 1 | 3% | $82.6M |
| April 2026 | 1 | 3% | $5.1M |
| March 2026 | 4 | 12% | $44.3M |
| February 2026 | 1 | 3% | $8.1M |
| January 2026 | 2 | 6% | $37.1M |
| December 2025 | 3 | 9% | $56.7M |
| November 2025 | 1 | 3% | $9.2M |
Table 7. Health care startups that raised Series A in the United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 30 | 14% | $851.1M |
| 2025 | 24 | 11% | $926.2M |
| 2024 | 13 | 6% | $408.4M |
| 2023 | 19 | 9% | $313.8M |
| 2022 | 31 | 14% | $399.6M |
| 2021 | 18 | 8% | $269.1M |
Table 8. Health care startups that raised Series A in the United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 12 | 6% |
| 2020 to 2022 | 42 | 20% |
| 2015 to 2019 | 89 | 42% |
| 2010 to 2014 | 47 | 22% |
| Before 2010 | 23 | 11% |
Table 9. Health care startups that raised Series A in the United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 53 | 25% |
| 11 to 50 | 128 | 61% |
| 51 to 100 | 18 | 9% |
| 101 to 250 | 7 | 3% |
| 251 to 500 | 1 | 0% |
| 501 to 1,000 | 2 | 1% |
| 1,001 to 5,000 | 1 | 0% |
| 10,001 or more | 1 | 0% |
Table 10. Health care startups that raised Series A in the United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series A and its headquarters is in the United Kingdom. On 16 November 2026 that is 214 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 21 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 214 rows: 24 have no round amount, 0 no city and 60 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in the United Kingdom whose last round is Series A are on the list?
- 214, in the file dated 16 November 2026. 34 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 214 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.